E
Cogent Biosciences, Inc. COGT
$12.23 $0.443.73% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -73.53M -71.99M -67.93M -70.63M -58.95M
Total Depreciation and Amortization 1.16M 1.14M 1.11M 1.10M 1.08M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 10.00M 9.05M 7.37M 4.16M 12.59M
Change in Net Operating Assets 7.84M -4.72M -1.13M 13.40M 2.58M
Cash from Operations -54.54M -66.51M -60.58M -51.98M -42.70M
Capital Expenditure -131.00K -547.00K -75.00K -280.00K -148.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 9.04M 69.93M 61.75M 60.47M -84.48M
Cash from Investing 8.91M 69.38M 61.67M 60.19M -84.63M
Total Debt Issued 49.29M -- -- -- --
Total Debt Repaid -2.07M -- -- -- --
Issuance of Common Stock 705.00K 24.97M 126.00K 624.00K 11.34M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -700.00K -- 11.50M 0.00 -11.60M
Cash from Financing 47.23M 24.97M 26.00K 624.00K -256.00K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 1.60M 27.84M 1.12M 8.83M -127.58M